Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nanotubes, Carbon | 9 | 2020 | 71 | 2.710 |
Why?
|
Hydrogels | 14 | 2020 | 723 | 2.490 |
Why?
|
Tissue Engineering | 12 | 2020 | 1870 | 1.900 |
Why?
|
Graphite | 6 | 2019 | 76 | 1.750 |
Why?
|
Tissue Scaffolds | 10 | 2020 | 928 | 1.660 |
Why?
|
Gelatin | 9 | 2018 | 221 | 1.500 |
Why?
|
Myocardium | 7 | 2020 | 4700 | 1.070 |
Why?
|
Biocompatible Materials | 8 | 2020 | 1689 | 0.810 |
Why?
|
Myocytes, Cardiac | 6 | 2020 | 1657 | 0.740 |
Why?
|
Microelectrodes | 1 | 2020 | 304 | 0.640 |
Why?
|
Myofibroblasts | 1 | 2019 | 207 | 0.570 |
Why?
|
Electricity | 1 | 2018 | 182 | 0.560 |
Why?
|
Ink | 2 | 2016 | 47 | 0.550 |
Why?
|
Neovascularization, Physiologic | 2 | 2020 | 1336 | 0.510 |
Why?
|
Stress, Mechanical | 2 | 2019 | 1666 | 0.500 |
Why?
|
Sound | 1 | 2017 | 257 | 0.490 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2019 | 432 | 0.470 |
Why?
|
Extracellular Matrix | 3 | 2019 | 1726 | 0.450 |
Why?
|
Robotics | 1 | 2020 | 874 | 0.420 |
Why?
|
Diabetic Retinopathy | 1 | 2020 | 1268 | 0.370 |
Why?
|
Nanocapsules | 1 | 2011 | 92 | 0.370 |
Why?
|
Myocardial Contraction | 2 | 2020 | 1516 | 0.360 |
Why?
|
Ionic Liquids | 1 | 2008 | 10 | 0.310 |
Why?
|
Electrochemistry | 1 | 2008 | 143 | 0.300 |
Why?
|
Electric Conductivity | 3 | 2016 | 410 | 0.270 |
Why?
|
Mesenchymal Stem Cells | 2 | 2020 | 1634 | 0.270 |
Why?
|
Rats, Sprague-Dawley | 5 | 2020 | 8158 | 0.260 |
Why?
|
Rats | 6 | 2020 | 23711 | 0.250 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2011 | 2128 | 0.250 |
Why?
|
Child of Impaired Parents | 1 | 2008 | 459 | 0.240 |
Why?
|
Biomedical Research | 1 | 2020 | 3426 | 0.230 |
Why?
|
Oxides | 3 | 2015 | 401 | 0.220 |
Why?
|
Protons | 1 | 2009 | 1114 | 0.220 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2008 | 2502 | 0.210 |
Why?
|
NIH 3T3 Cells | 3 | 2013 | 670 | 0.210 |
Why?
|
Blood Vessels | 2 | 2020 | 1112 | 0.210 |
Why?
|
Ethanol | 1 | 2008 | 1323 | 0.200 |
Why?
|
Ultraviolet Rays | 3 | 2017 | 1078 | 0.200 |
Why?
|
Cell Survival | 4 | 2017 | 5797 | 0.190 |
Why?
|
Microscopy, Electron, Transmission | 2 | 2016 | 697 | 0.190 |
Why?
|
Polymers | 3 | 2017 | 1621 | 0.180 |
Why?
|
DNA | 2 | 2016 | 7233 | 0.170 |
Why?
|
Child Abuse | 1 | 2008 | 1067 | 0.170 |
Why?
|
Animals | 13 | 2020 | 167963 | 0.160 |
Why?
|
Ventricular Remodeling | 3 | 2011 | 1261 | 0.160 |
Why?
|
Biomimetics | 1 | 2020 | 173 | 0.160 |
Why?
|
Integrin alpha2beta1 | 1 | 2017 | 17 | 0.150 |
Why?
|
Mechanotransduction, Cellular | 2 | 2020 | 530 | 0.150 |
Why?
|
Alcoholism | 1 | 2008 | 1961 | 0.150 |
Why?
|
Myocardial Infarction | 4 | 2011 | 11891 | 0.140 |
Why?
|
Surface Properties | 1 | 2020 | 1161 | 0.140 |
Why?
|
Microscopy, Electron, Scanning | 2 | 2016 | 941 | 0.140 |
Why?
|
Cells, Cultured | 5 | 2019 | 18957 | 0.140 |
Why?
|
Materials Testing | 1 | 2020 | 862 | 0.130 |
Why?
|
Tropoelastin | 1 | 2015 | 28 | 0.130 |
Why?
|
Polyethylene Terephthalates | 1 | 2016 | 115 | 0.130 |
Why?
|
Particle Size | 1 | 2020 | 1644 | 0.130 |
Why?
|
Electrochemical Techniques | 1 | 2016 | 95 | 0.130 |
Why?
|
Embryonic Development | 1 | 2020 | 716 | 0.120 |
Why?
|
Fibroblasts | 2 | 2017 | 4090 | 0.120 |
Why?
|
Fibrosis | 2 | 2019 | 2042 | 0.120 |
Why?
|
Decanoates | 1 | 2014 | 55 | 0.120 |
Why?
|
Automation | 1 | 2017 | 580 | 0.120 |
Why?
|
Polyethylene Glycols | 1 | 2020 | 1189 | 0.120 |
Why?
|
Organ Culture Techniques | 1 | 2016 | 796 | 0.110 |
Why?
|
Elasticity | 1 | 2015 | 652 | 0.110 |
Why?
|
Glycerol | 1 | 2014 | 276 | 0.110 |
Why?
|
Cartilage, Articular | 1 | 2020 | 1091 | 0.110 |
Why?
|
Porosity | 1 | 2013 | 349 | 0.100 |
Why?
|
Regenerative Medicine | 1 | 2016 | 307 | 0.100 |
Why?
|
Hyaluronic Acid | 1 | 2016 | 482 | 0.100 |
Why?
|
Mechanical Phenomena | 1 | 2013 | 140 | 0.100 |
Why?
|
Equipment Failure Analysis | 2 | 2011 | 848 | 0.100 |
Why?
|
Oxidation-Reduction | 2 | 2009 | 2222 | 0.100 |
Why?
|
Models, Cardiovascular | 1 | 2017 | 978 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 1347 | 0.100 |
Why?
|
Biomedical Engineering | 1 | 2013 | 289 | 0.100 |
Why?
|
Liquid Crystals | 1 | 2011 | 21 | 0.100 |
Why?
|
Biomimetic Materials | 1 | 2013 | 173 | 0.090 |
Why?
|
Refractometry | 1 | 2011 | 57 | 0.090 |
Why?
|
Organoids | 1 | 2017 | 729 | 0.090 |
Why?
|
Data Display | 1 | 2011 | 174 | 0.090 |
Why?
|
Biosensing Techniques | 1 | 2017 | 677 | 0.090 |
Why?
|
Analog-Digital Conversion | 1 | 2010 | 23 | 0.090 |
Why?
|
Nanomedicine | 1 | 2013 | 288 | 0.090 |
Why?
|
Fumarates | 1 | 2011 | 131 | 0.090 |
Why?
|
Equipment Design | 3 | 2016 | 3520 | 0.090 |
Why?
|
Carbon | 1 | 2013 | 669 | 0.080 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1664 | 0.080 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2015 | 806 | 0.080 |
Why?
|
Heart Failure | 2 | 2011 | 11847 | 0.080 |
Why?
|
Renin | 1 | 2011 | 635 | 0.080 |
Why?
|
Circular Dichroism | 1 | 2009 | 348 | 0.080 |
Why?
|
Viologens | 1 | 2008 | 1 | 0.080 |
Why?
|
Microscopy | 1 | 2013 | 885 | 0.080 |
Why?
|
Amides | 1 | 2011 | 448 | 0.080 |
Why?
|
Valine | 1 | 2010 | 409 | 0.080 |
Why?
|
Cardiotonic Agents | 1 | 2011 | 546 | 0.070 |
Why?
|
Nanotechnology | 1 | 2013 | 709 | 0.070 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2010 | 435 | 0.070 |
Why?
|
Cytokines | 2 | 2019 | 7343 | 0.070 |
Why?
|
Adolescent Health Services | 1 | 2008 | 218 | 0.070 |
Why?
|
Motion | 1 | 2010 | 779 | 0.070 |
Why?
|
Molecular Imaging | 1 | 2013 | 818 | 0.070 |
Why?
|
Death | 1 | 2010 | 678 | 0.060 |
Why?
|
Cardiomyopathies | 1 | 2017 | 1952 | 0.060 |
Why?
|
Cryoelectron Microscopy | 1 | 2009 | 642 | 0.060 |
Why?
|
Video Recording | 1 | 2010 | 955 | 0.060 |
Why?
|
Diabetes Complications | 1 | 2011 | 1341 | 0.060 |
Why?
|
Tetrazoles | 1 | 2010 | 905 | 0.060 |
Why?
|
Endothelial Cells | 1 | 2016 | 3539 | 0.060 |
Why?
|
Ultrasonography | 3 | 2011 | 5961 | 0.050 |
Why?
|
Nanoparticles | 1 | 2013 | 1943 | 0.050 |
Why?
|
Humans | 15 | 2020 | 760621 | 0.050 |
Why?
|
Microscopy, Confocal | 2 | 2017 | 1972 | 0.040 |
Why?
|
Vinculin | 1 | 2017 | 59 | 0.040 |
Why?
|
Mice | 3 | 2013 | 81208 | 0.040 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2017 | 119 | 0.040 |
Why?
|
Mannose-Binding Lectins | 1 | 2017 | 96 | 0.040 |
Why?
|
Compressive Strength | 1 | 2017 | 157 | 0.030 |
Why?
|
Bioartificial Organs | 1 | 2016 | 47 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2011 | 10446 | 0.030 |
Why?
|
Hexuronic Acids | 1 | 2015 | 145 | 0.030 |
Why?
|
Glucuronic Acid | 1 | 2015 | 150 | 0.030 |
Why?
|
Engineering | 1 | 2015 | 56 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 12531 | 0.030 |
Why?
|
Bioreactors | 1 | 2016 | 244 | 0.030 |
Why?
|
Viscosity | 1 | 2015 | 335 | 0.030 |
Why?
|
Tensile Strength | 1 | 2015 | 330 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2015 | 548 | 0.030 |
Why?
|
Alginates | 1 | 2015 | 248 | 0.030 |
Why?
|
Nanofibers | 1 | 2014 | 66 | 0.030 |
Why?
|
Cell Polarity | 1 | 2017 | 638 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2017 | 587 | 0.030 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2013 | 201 | 0.030 |
Why?
|
Interleukin-4 | 1 | 2017 | 1130 | 0.030 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2017 | 608 | 0.030 |
Why?
|
Methacrylates | 1 | 2013 | 109 | 0.030 |
Why?
|
Biodegradation, Environmental | 1 | 2013 | 218 | 0.030 |
Why?
|
Polymerization | 1 | 2013 | 157 | 0.030 |
Why?
|
Disease Progression | 1 | 2010 | 13502 | 0.030 |
Why?
|
Prognosis | 2 | 2010 | 29658 | 0.030 |
Why?
|
Cytoskeleton | 1 | 2017 | 1167 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2008 | 14495 | 0.030 |
Why?
|
Microfluidics | 1 | 2017 | 652 | 0.020 |
Why?
|
Perfusion | 1 | 2016 | 1376 | 0.020 |
Why?
|
Ligands | 1 | 2017 | 3276 | 0.020 |
Why?
|
Temperature | 1 | 2016 | 2221 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2017 | 2209 | 0.020 |
Why?
|
Electromagnetic Fields | 1 | 2011 | 296 | 0.020 |
Why?
|
Systole | 1 | 2011 | 947 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2010 | 39261 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 2825 | 0.020 |
Why?
|
Stem Cells | 1 | 2020 | 3523 | 0.020 |
Why?
|
Risk Assessment | 1 | 2008 | 24123 | 0.020 |
Why?
|
Male | 5 | 2011 | 359744 | 0.020 |
Why?
|
Aged | 4 | 2011 | 169152 | 0.020 |
Why?
|
Models, Molecular | 1 | 2015 | 5434 | 0.020 |
Why?
|
Female | 5 | 2011 | 391270 | 0.020 |
Why?
|
Gene Expression | 1 | 2017 | 7588 | 0.010 |
Why?
|
Middle Aged | 4 | 2011 | 220352 | 0.010 |
Why?
|
Heart | 1 | 2017 | 4393 | 0.010 |
Why?
|
Cell Line | 1 | 2017 | 15620 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11481 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 2011 | 1572 | 0.010 |
Why?
|
Macrophages | 1 | 2017 | 5745 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16546 | 0.010 |
Why?
|
Young Adult | 1 | 2008 | 58741 | 0.010 |
Why?
|
Liver | 1 | 2017 | 7509 | 0.010 |
Why?
|
Models, Biological | 1 | 2017 | 9467 | 0.010 |
Why?
|
Child | 1 | 2008 | 79806 | 0.010 |
Why?
|
Adolescent | 1 | 2008 | 87810 | 0.010 |
Why?
|
Recurrence | 1 | 2011 | 8482 | 0.010 |
Why?
|
Blood Pressure | 1 | 2011 | 8525 | 0.010 |
Why?
|
Hospitalization | 1 | 2011 | 10790 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2011 | 65017 | 0.000 |
Why?
|
Concepts
(176)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_